Cell Line : M-07E
Cellosaurus Index : CVCL_2106
Cellosaurus ID : M-07E
CCLE Name
: M07E_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
CTRP2 Name
: M07E
Cancer Type : haematopoietic_and_lymphoid_tissue
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| M-07E | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 |
|
| M-07E | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | A-804598 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | AA-COCF3 | CTRP2 | 0.0081 | 270.0000 |
|
| M-07E | ABT737 | CTRP2 | 0.0011 | 37.0000 |
|
| M-07E | Afatinib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | AGK-2 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | Alisertib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| M-07E | Alpelisib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | alvocidib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| M-07E | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | ASN 05257430 | CTRP2 | 0.0011 | 37.0000 |
|
| M-07E | AT-406 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | AT13387 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | AT7867 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | austocystin D | CTRP2 | 0.0011 | 37.0000 |
|
| M-07E | avicin D | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | avrainvillamide | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | Axitinib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | AZD-7545 | CTRP2 | 0.0023 | 74.0000 |
|
| M-07E | AZD1480 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | AZD4547 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | AZD6482 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | AZD7762 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | AZD8055 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| M-07E | bafilomycin A1 | CTRP2 | 0.0000 | 0.3300 |
|
| M-07E | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Bax channel blocker | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | BCL-LZH-4 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Belinostat | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Bexarotene | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BI-2536 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | BIBR-1532 | CTRP2 | 0.0081 | 270.0000 |
|
| M-07E | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BIX-01294 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BMS-345541 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BMS-536924 | CTRP2 | 0.0011 | 37.0000 |
|
| M-07E | BMS-754807 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | Bortezomib | CTRP2 | 0.0000 | 0.1300 |
|
| M-07E | Bosutinib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| M-07E | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| M-07E | BRD-A05715709 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | BRD-A86708339 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K01737880 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K03536150 | CTRP2 | 0.0081 | 270.0000 |
|
| M-07E | BRD-K04800985 | CTRP2 | 0.0020 | 67.0000 |
|
| M-07E | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K13999467 | CTRP2 | 0.0020 | 67.0000 |
|
| M-07E | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K17060750 | CTRP2 | 0.0020 | 67.0000 |
|
| M-07E | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| M-07E | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K30748066 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K33199242 | CTRP2 | 0.0020 | 67.0000 |
|
| M-07E | BRD-K33514849 | CTRP2 | 0.0010 | 34.0000 |
|
| M-07E | BRD-K34222889 | CTRP2 | 0.0017 | 57.0000 |
|
| M-07E | BRD-K35604418 | CTRP2 | 0.0081 | 270.0000 |
|
| M-07E | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | BRD-K41597374 | CTRP2 | 0.0020 | 67.0000 |
|
| M-07E | BRD-K42260513 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K48477130 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K50799972 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K51831558 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K55116708 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K55473186 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K63431240 | CTRP2 | 0.0009 | 30.0000 |
|
| M-07E | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| M-07E | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K90370028 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| M-07E | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-K99006945 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD-M00053801 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| M-07E | BRD4132 | CTRP2 | 0.0049 | 160.0000 |
|
| M-07E | BRD55319 | CTRP2 | 0.0011 | 37.0000 |
|
| M-07E | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | BRD6430 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | BRD8958 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| M-07E | BRD9876:MK-1775 (4:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Cabozantinib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 48.0000 |
|
| M-07E | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| M-07E | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | CAY10594 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | CBB-1007 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | CD-1530 | CTRP2 | 0.0041 | 130.0000 |
|
| M-07E | CD-437 | CTRP2 | 0.0011 | 37.0000 |
|
| M-07E | Cediranib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | cerulenin | CTRP2 | 0.0045 | 150.0000 |
|
| M-07E | Ch-55 | CTRP2 | 0.0020 | 17.0000 |
|
| M-07E | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| M-07E | CHEMBL374350 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | CHIR-99021 | CTRP2 | 0.0024 | 80.0000 |
|
| M-07E | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| M-07E | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| M-07E | CI-976 | CTRP2 | 0.0081 | 270.0000 |
|
| M-07E | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | ciclosporin | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | COL-3 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Compound 1541A | CTRP2 | 0.0011 | 37.0000 |
|
| M-07E | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Compound 23 citrate | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | Compound 7d-cis | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | Crizotinib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| M-07E | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| M-07E | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | cytochalasin B | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Dactolisib | CTRP2 | 0.0005 | 17.0000 |
|
| M-07E | Daporinad | CTRP2 | 0.0001 | 2.0000 |
|
| M-07E | Dasatinib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| M-07E | dexamethasone | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | Dinaciclib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Docetaxel | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| M-07E | Doramapimod | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Doxorubicin | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| M-07E | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Entinostat | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| M-07E | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Erlotinib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| M-07E | etomoxir | CTRP2 | 0.0090 | 300.0000 |
|
| M-07E | Etoposide | CTRP2 | 0.0009 | 28.0000 |
|
| M-07E | ETP-46464 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Fedratinib | CTRP2 | 0.0011 | 37.0000 |
|
| M-07E | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| M-07E | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Foretinib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| M-07E | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Gefitinib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Gemcitabine | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | GMX-1778 | CTRP2 | 0.0000 | 0.3000 |
|
| M-07E | gossypol | CTRP2 | 0.0011 | 37.0000 |
|
| M-07E | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | GSK-J4 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | GSK1059615 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | GSK2636771 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | GW-405833 | CTRP2 | 0.0041 | 130.0000 |
|
| M-07E | GW843682X | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | HBX-41108 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | hyperforin | CTRP2 | 0.0020 | 33.0000 |
|
| M-07E | I-BET151 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Ibrutinib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | IC-87114 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| M-07E | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | isonicotinohydroxamic acid | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| M-07E | istradefylline | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | itraconazole | CTRP2 | 0.0005 | 17.0000 |
|
| M-07E | IU1 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| M-07E | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| M-07E | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| M-07E | JQ1 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | JW-74 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | KH-CB19 | CTRP2 | 0.0005 | 17.0000 |
|
| M-07E | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| M-07E | KPT185 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | KU-55933 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | KU-60019 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | L-685458 | CTRP2 | 0.0011 | 37.0000 |
|
| M-07E | Lapatinib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | LE-135 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Linifanib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Linsitinib | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | lovastatin acid | CTRP2 | 0.0041 | 66.0000 |
|
| M-07E | LRRK2-IN-1 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | LY-2183240 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| M-07E | marinopyrrole A | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Masitinib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | Methotrexate | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | methylstat | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | MI-2 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | MIRA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| M-07E | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | MK-1775 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | MK-2206 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | ML006 | CTRP2 | 0.0160 | 530.0000 |
|
| M-07E | ML030 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | ML050 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | ML203 | CTRP2 | 0.0011 | 37.0000 |
|
| M-07E | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| M-07E | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | ML334 diastereomer | CTRP2 | 0.0041 | 130.0000 |
|
| M-07E | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | MLN2480 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | N9-isopropylolomoucine | CTRP2 | 0.0120 | 400.0000 |
|
| M-07E | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | Navitoclax | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| M-07E | necrostatin-1 | CTRP2 | 0.0160 | 530.0000 |
|
| M-07E | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | necrosulfonamide | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Nelarabine | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | Nilotinib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| M-07E | NSC 74859 | CTRP2 | 0.0160 | 530.0000 |
|
| M-07E | NSC23766 | CTRP2 | 0.0160 | 270.0000 |
|
| M-07E | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | NSC632839 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | NSC95397 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | Nutlin-3a | CTRP2 | 0.0045 | 150.0000 |
|
| M-07E | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | NVP-ADW742 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | NVP-TAE684 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | O-6-benzylguanine | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Obatoclax Mesylate | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Olaparib | CTRP2 | 0.0045 | 150.0000 |
|
| M-07E | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | omacetaxine mepesuccinate | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | OSI-027 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | OSI-930 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| M-07E | Oxaliplatin | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | PAC-1 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | Paclitaxel | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | palmostatin B | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Parthenolide | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Pazopanib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | PD 153035 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | PDMP | CTRP2 | 0.0065 | 210.0000 |
|
| M-07E | Pevonedistat | CTRP2 | 0.0011 | 37.0000 |
|
| M-07E | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | PF-3758309 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | PF-750 | CTRP2 | 0.0081 | 270.0000 |
|
| M-07E | PHA-793887 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | phloretin | CTRP2 | 0.0180 | 590.0000 |
|
| M-07E | PI-103 | CTRP2 | 0.0011 | 37.0000 |
|
| M-07E | Pictilisib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| M-07E | pifithrin-mu | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | PIK-93 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Piperlongumine | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | pitstop2 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | PL-DI | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | PLX-4720 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | PRIMA-1 | CTRP2 | 0.0051 | 170.0000 |
|
| M-07E | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| M-07E | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | purmorphamine | CTRP2 | 0.0046 | 150.0000 |
|
| M-07E | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| M-07E | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Quizartinib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | R428 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | RAF265 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Rapamycin | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Repligen 136 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | RG-108 | CTRP2 | 0.0081 | 270.0000 |
|
| M-07E | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | RITA | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | Ruxolitinib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| M-07E | Saracatinib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| M-07E | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| M-07E | Selumetinib | CTRP2 | 0.0081 | 270.0000 |
|
| M-07E | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| M-07E | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| M-07E | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| M-07E | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| M-07E | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| M-07E | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| M-07E | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| M-07E | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| M-07E | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| M-07E | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| M-07E | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| M-07E | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Sepantronium bromide | CTRP2 | 0.0000 | 1.0000 |
|
| M-07E | Serdemetan | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | SID 26681509 | CTRP2 | 0.0090 | 300.0000 |
|
| M-07E | sildenafil | CTRP2 | 0.0160 | 530.0000 |
|
| M-07E | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | simvastatin | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| M-07E | SJ-172550 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | skepinone-L | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | SKI-II | CTRP2 | 0.0041 | 130.0000 |
|
| M-07E | SMER-3 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | SN-38 | CTRP2 | 0.0000 | 1.3000 |
|
| M-07E | SNS-032 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | SNX-2112 | CTRP2 | 0.0011 | 37.0000 |
|
| M-07E | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| M-07E | Sorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | sotrastaurin | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Sphingosine Kinase 1 Inhibitor II | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | SR8278 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | SZ4TA2 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | tacedinaline | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | tacrolimus | CTRP2 | 0.0023 | 74.0000 |
|
| M-07E | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | Tamoxifen | CTRP2 | 0.0030 | 100.0000 |
|
| M-07E | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Tanespimycin | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| M-07E | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | Telomerase Inhibitor IX | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | Temozolomide | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Thalidomide | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | tivantinib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Tivozanib | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | Topotecan | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | TPCA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Trametinib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Tretinoin | CTRP2 | 0.0041 | 130.0000 |
|
| M-07E | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| M-07E | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| M-07E | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | triptolide | CTRP2 | 0.0000 | 0.3000 |
|
| M-07E | TW 37 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | UNC0638 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | VAF-347 | CTRP2 | 0.0020 | 33.0000 |
|
| M-07E | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Veliparib | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | Venetoclax | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| M-07E | Vincristine | CTRP2 | 0.0081 | 130.0000 |
|
| M-07E | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | Vorinostat | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | VX-680 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | WZ4002 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| M-07E | YK-4-279 | CTRP2 | 0.0010 | 33.0000 |
|
| M-07E | YL54 | CTRP2 | 0.0020 | 33.0000 |
|
| M-07E | zebularine | CTRP2 | 0.0180 | 590.0000 |
|
| M-07E | ZSTK474 | CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC